My research efforts over the years have been concentrated in finding new therapeutic strategies for the treatment of chronic liver diseases. I completed my PhD in Vall d’Hebron Research Institute (VHIR) in the group of Dr. Joan Genescà with a scientific output of 11 publications, 3 of them as a first author (J Hepatol 2008; Liver Int 2010; Hepatology 2012). To further increase my understanding of the molecular basis of liver diseases, in 2011 I moved to IDIBAPS to Liver cell plasticity and tissue repair group led by Pau Sancho-Bru. During the first three years of my post-doc I was funded by a European project (FP7-HEALTH -2010) which aimed at generating a microfluidic device comprising liver cells differentiated from induced pluripotent stem cells (iPSC) to mimic the liver structure. Then, I was awarded with an exchange program that allowed me to work in Dr. Verfaillie’s Laboratory (Stem Cell Institute, Leuven, Belgium) where we described for the first time a protocol for differentiating iPSC towards hepatic stellate cells (Coll M, Cell Stem Cell 2018). This method and its use were patented by IDIBAPS and Katholieke Universiteit Leuven (KUL). Then, I was award with a Sara Borrell contract from Institute of Health Carlos III (ISCIII) and I centered my investigations on understanding liver regeneration processes including fibrogenesis and angiogenesis underlying chronic liver diseases, (Coll M, Sci Reports 2015 and Coll M, Hepatology 2021,). In 2016 I started to take part of CIBERehd as a senior post-doctoral researcher in the group of Dr. Pere Ginès. To further increase my understanding in liver inflammation I moved to the laboratory of Dr. Paul Kubes at the University of Calgary (Canada), the world’s leading expert on inflammation and imaging of the immune system. In collaboration with Dr. Kubes, I conducted a study based on the characterization of human liver macrophages in chronic liver disease (Pose E, Hepatology 202, I am the corresponding author). Overall, my post-doctoral research has produced 20 publications, three of them as first author, two as corresponding and one as a senior author. In 2019 I debuted as a principal investigator of a grant funded ISCIII. This grant gave me the opportunity to start my research line focused on understanding the adipose tissue-liver axis during the progression of non-alcoholic fatty liver disease (NAFLD). In January 2021, I was awarded with the Ramon y Cajal Program, a prestigious individual fellowship (Government of Spain) to support starting PIs. Since then, I have started as a Junior Researcher at the Medicine department of the University of Barcelona, where I have established my independent translational research group. We are a multidisciplinary team composed by Dr. Isabel Graupera, Senior specialist in Hepatology and responsible of the area of NAFLD at Hospital Clínic de Barcelona; Octavi Bassegoda, a Medical PhD researcher and Celia Martínez, a basic PhD researcher. We are currently investigating a novel strategy to interfere in NAFLD progression by modulating the macrophage phenotype with the administration of nanotransporters conjugated with anti-inflammatory molecules, developed by Dr. Smith (University of Illinois, USA) (abstract submitted in ILC 2022 and manuscript on preparation). Over the years, the international recognition of my research in the hepatology field has been reflected by 1) invitations to present my work in international meetings (ILC 2014, London; ILC 2015, Viena and ILC 2018, Paris) and International liver School (EASL 2018, Barcelona); 2) reviewing research grants of National French Research Agency (ANR) (2021); 3) regularly reviewing papers for the high impact journals in the hepatology field and finally 4) reviewing abstracts submitted in the Hepatic Fibrosis category of the ILC 2021 (on-line) and 2022 (London). My formation capacity has been demonstrated by my participation as lecturer in three masters: Master in clinical Investigation (UB) (2016-present); Master in Translational Research (UB) (2021-2022) and Master in Translational Biomedical Research (VHIR-UAB) (219-present) and also by being a lecturer in BSc degree in Biomedical Sciences (UB) (2021-present). In addition I have supervised 4 master thesis (2018,2019,2020) and I am co-director of 2 PhD thesis (Elisa Pose, 2021 and Celia Martinez, to be defended in 2022). Finally, I am a member of the Scientific committee of the Catalan Society of Digestology (SCD) consisting in reviewing abstracts for the SCD meetings and organizing the “Translational research course on digestology diseases” (Barcelona 2021, Girona 2022). Overall, during my career, including 3 maternity leaves, I have produced 38 publications with a total times cited of 927, an average citation/year of 71.2 and my H-Index is 17 (Web of Science).